More Remicade news
On the one hand, the FDA has approved Remicade for the treatment of ankylosing spondylitis. (The EU had already done so.) But on the other hand, the FDA and the drug manufacturer also warned that Remicade has been linked to rare and occasionally deadly liver reactions. (See previous entry.)
Comments on this post
Post a Comment
Links to this post
Create a Link